Globus Medical
GMED
354 hedge funds and large institutions have $5.2B invested in Globus Medical in 2021 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 123 increasing their positions, 113 reducing their positions, and 37 closing their positions.
877% more call options, than puts
Call options by funds: $23.9M | Put options by funds: $2.45M
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
25% more capital invested
Capital invested by funds: $4.17B → $5.2B (+$1.03B)
24% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 37
3% more funds holding
Funds holding: 345 → 354 (+9)
9% more repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 113
0.02% more ownership
Funds ownership: 87.67% → 87.69% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$36M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$20.8M |
| 3 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$17.8M |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VBA
Van Berkom & Associates
Montreal,
Quebec, Canada
|
-$23.5M |
| 2 |
NI
Nuance Investments
Kansas City,
Missouri
|
-$19.1M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$18.9M |
| 4 |
BlackRock
New York
|
-$15.4M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$14.1M |
GMED Hedge Fund Activity: Q2 2021 in Review
354 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2021, worth a combined $5.2B — up 25% from $4.17B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new GMED positions and 37 closed out — a net gain of 9 holders — while 123 added to existing stakes and 113 trimmed.
The largest buyer was Consonance Capital Management, adding an estimated $36M. The largest seller was Van Berkom & Associates, cutting an estimated $23.5M.
- 354 institutional investors held Globus Medical (GMED) as of Q2 2021, up from 345 in Q1 2021.
- Funds reported $5.2B of Globus Medical stock for Q2 2021, up 25% quarter-over-quarter.
- 46 funds opened new Globus Medical positions in Q2 2021 and 37 closed out, a net change of +9 holders.
- The largest Globus Medical buyer in Q2 2021 was Consonance Capital Management, an estimated $36M added.
- The largest Globus Medical seller in Q2 2021 was Van Berkom & Associates, an estimated $23.5M sold.
Based on aggregated 13F filings for Q2 2021.